User login
An intensive lifestyle intervention produced significant improvements in weight, cardiovascular fitness, blood pressure, hemoglobin A1c, triglycerides, and HDL-cholesterol, which were largely maintained throughout 4 years of follow-up, according to a report in the Sept. 27 issue of the Archives of Internal Medicine.
The study, involving 5,145 overweight or obese patients with type 2 diabetes, compared the intensive intervention against usual patient care, which included standard diabetes education. “Effects of the magnitude that we observed for fitness, HDL-C and HbA1c levels, and blood pressure have been associated with decreased cardiovascular events and mortality in previous medication trials and observational studies.
“The critical question is whether the differences between groups in risk factors will translate into differences in the development of CVD [cardiovascular disease]. These results will not be available for several additional years,” said Rena R. Wing, Ph.D., of the department of psychiatry at Miriam Hospital/ Brown University, Providence, R.I., and her associates in the LookAHEAD (Action for Health in Diabetes) trial.
The LookAHEAD researchers previously reported on the 1-year benefits of the intensive lifestyle intervention, compared with usual care. They now report that patients who received the intervention were able to maintain the positive changes they made for 3 more years, albeit with some degree of regression to baseline levels of all measures.
The trial enrolled subjects aged 45-76 years at 16 U.S. medical centers. Approximately 60% of the subjects were women, and 37% were from racial or ethnic minorities. The average body mass index was 36 kg/m2, and the average duration of diabetes was more than 6 years.
A total of 2,570 subjects were randomly assigned to the intensive intervention and 2,575 to usual care with diabetes education.
The intervention included dietary modification with a calorie goal of 1,200-1,800 kcal/d, less than 30% of calories from fat, and at least 15% of calories from protein. A portion-controlled diet was provided. The exercise goal was at least 175 minutes of physical activity per week at an intensity level comparable to that of brisk walking. Behavioral strategies included self-monitoring, goal setting, and problem solving.
Subjects in the intervention group met individually and in groups every week for the first 6 months and 3 times per month for the next 6 months. During years 2 through 4, they were seen individually at least once a month, contacted by phone or e-mail once a month, and attended three group sessions and assorted group classes throughout the year.
These sessions were led by registered dieticians, behavioral counselors, or exercise specialists trained in lifestyle counseling. At each session, subjects were weighed, their self-monitoring records were reviewed, and a new lesson was presented.
Complete physical assessments were performed annually, and subjects were given a $100 honorarium to encourage participation.
“Averaged across the 4 years, participants in the [intervention] group experienced greater improvements in weight, fitness, glycemic control, blood pressure, and levels of HDL-C and triglycerides than those in the [usual care] group,” Dr. Wing and her colleagues said (Arch. Intern. Med. 2010;170:1566-75).
“The mean maximal weight loss (8.6%) in the [intervention] group occurred at 1 year, but participants ... maintained a mean weight loss of 4.7% at year 4, compared with 1.1% in the [usual-care] group,” they noted.
At 1-year follow-up, cardiovascular fitness increased by 20% in the intervention group and 5% in the usual-care group. It regressed over time, but at year 4 the fitness level of the intervention group was still 5% over the baseline level, while that of the usual-care group was 1% below baseline level.
The intervention group maintained greater improvements than did the usual-care group in systolic blood pressure, HbA1c levels, and HDL-C levels, but initial improvements in diastolic blood pressure and triglycerides disappeared by year 4. There were no differences between the two groups in improvement in LDL-C levels.
“This study shows that lifestyle interventions can produce long-term weight loss and improvement in fitness and sustained beneficial effects on CVD risk factors,” the investigators said.
“Although the differences between the two groups were greatest initially and decreased over time for several measures, the differences between the groups averaged across the 4 years were substantial and indicate that the [intervention] group spent a considerable time at lower CVD risk,” they added.
“Longer follow-up will allow us to determine whether the differences between groups in CVD risk factors can be maintained and whether the [intensive intervention] has positive effects on cardiovascular morbidity and mortality,” Dr. Wing and her associates said.
Disclosures: The LookAHEAD study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; Office of Research on Women’s Health; Centers for Disease Control and Prevention; U.S. Department of Veterans Affairs; Indian Health Service; and general clinical research centers at Johns Hopkins Medical Institutions, Massachusetts General Hospital, Massachusetts Institute of Technology, Colorado Health Sciences Center, University of Tennessee at Memphis, and the University of Pittsburgh. In addition, FedEx Corp., Health Management Resources, LifeScan Inc., OPTIFAST, Hoffmann-La Roche, Abbott Nutrition, and Slim-Fast have committed to make major contributions to the ongoing trial. Dr. Wing’s associates reported financial ties to BodyMedia Inc., University of Pittsburgh Medical Center Health Plan, Proctor & Gamble, and Free & Clear.
For patients with type 2 diabetes, these exciting findings provide
solid evidence of the sustained benefit of simple interventions on
numerous important cardiovascular risk factors. The results are
particularly encouraging because, unlike drug therapy for the disorder,
lifestyle interventions carry little risk of inducing hypoglycemia, said
Dr. Prakash C. Deedwania.
However, it is unlikely that the
frequent and regular instruction, visits with registered dietitians and
exercise specialists, special diets given free of charge, and monetary
incentives used in this intervention can be translated on a broad scale
to clinical practice. And the recidivism that occurred over time toward
baseline levels raises questions about the long-term sustainability of
such an intensive intervention in everyday clinical practice.
Overall,
however, the LookAHEAD findings show that “simple, established
approaches based on conventional wisdom work well, and there is no need
to rush to newer or novel approaches unless convincing evidence supports
such a move,” he said.
Dr. Deedwania
is chief of cardiology at Veterans Affairs Central California Health
Care System, Fresno. He reported no relevant financial disclosures.
These comments are taken from his editorial accompanying the LookAHEAD
report (Arch. Intern. Med. 2010;170:1575-7).
For patients with type 2 diabetes, these exciting findings provide
solid evidence of the sustained benefit of simple interventions on
numerous important cardiovascular risk factors. The results are
particularly encouraging because, unlike drug therapy for the disorder,
lifestyle interventions carry little risk of inducing hypoglycemia, said
Dr. Prakash C. Deedwania.
However, it is unlikely that the
frequent and regular instruction, visits with registered dietitians and
exercise specialists, special diets given free of charge, and monetary
incentives used in this intervention can be translated on a broad scale
to clinical practice. And the recidivism that occurred over time toward
baseline levels raises questions about the long-term sustainability of
such an intensive intervention in everyday clinical practice.
Overall,
however, the LookAHEAD findings show that “simple, established
approaches based on conventional wisdom work well, and there is no need
to rush to newer or novel approaches unless convincing evidence supports
such a move,” he said.
Dr. Deedwania
is chief of cardiology at Veterans Affairs Central California Health
Care System, Fresno. He reported no relevant financial disclosures.
These comments are taken from his editorial accompanying the LookAHEAD
report (Arch. Intern. Med. 2010;170:1575-7).
For patients with type 2 diabetes, these exciting findings provide
solid evidence of the sustained benefit of simple interventions on
numerous important cardiovascular risk factors. The results are
particularly encouraging because, unlike drug therapy for the disorder,
lifestyle interventions carry little risk of inducing hypoglycemia, said
Dr. Prakash C. Deedwania.
However, it is unlikely that the
frequent and regular instruction, visits with registered dietitians and
exercise specialists, special diets given free of charge, and monetary
incentives used in this intervention can be translated on a broad scale
to clinical practice. And the recidivism that occurred over time toward
baseline levels raises questions about the long-term sustainability of
such an intensive intervention in everyday clinical practice.
Overall,
however, the LookAHEAD findings show that “simple, established
approaches based on conventional wisdom work well, and there is no need
to rush to newer or novel approaches unless convincing evidence supports
such a move,” he said.
Dr. Deedwania
is chief of cardiology at Veterans Affairs Central California Health
Care System, Fresno. He reported no relevant financial disclosures.
These comments are taken from his editorial accompanying the LookAHEAD
report (Arch. Intern. Med. 2010;170:1575-7).
An intensive lifestyle intervention produced significant improvements in weight, cardiovascular fitness, blood pressure, hemoglobin A1c, triglycerides, and HDL-cholesterol, which were largely maintained throughout 4 years of follow-up, according to a report in the Sept. 27 issue of the Archives of Internal Medicine.
The study, involving 5,145 overweight or obese patients with type 2 diabetes, compared the intensive intervention against usual patient care, which included standard diabetes education. “Effects of the magnitude that we observed for fitness, HDL-C and HbA1c levels, and blood pressure have been associated with decreased cardiovascular events and mortality in previous medication trials and observational studies.
“The critical question is whether the differences between groups in risk factors will translate into differences in the development of CVD [cardiovascular disease]. These results will not be available for several additional years,” said Rena R. Wing, Ph.D., of the department of psychiatry at Miriam Hospital/ Brown University, Providence, R.I., and her associates in the LookAHEAD (Action for Health in Diabetes) trial.
The LookAHEAD researchers previously reported on the 1-year benefits of the intensive lifestyle intervention, compared with usual care. They now report that patients who received the intervention were able to maintain the positive changes they made for 3 more years, albeit with some degree of regression to baseline levels of all measures.
The trial enrolled subjects aged 45-76 years at 16 U.S. medical centers. Approximately 60% of the subjects were women, and 37% were from racial or ethnic minorities. The average body mass index was 36 kg/m2, and the average duration of diabetes was more than 6 years.
A total of 2,570 subjects were randomly assigned to the intensive intervention and 2,575 to usual care with diabetes education.
The intervention included dietary modification with a calorie goal of 1,200-1,800 kcal/d, less than 30% of calories from fat, and at least 15% of calories from protein. A portion-controlled diet was provided. The exercise goal was at least 175 minutes of physical activity per week at an intensity level comparable to that of brisk walking. Behavioral strategies included self-monitoring, goal setting, and problem solving.
Subjects in the intervention group met individually and in groups every week for the first 6 months and 3 times per month for the next 6 months. During years 2 through 4, they were seen individually at least once a month, contacted by phone or e-mail once a month, and attended three group sessions and assorted group classes throughout the year.
These sessions were led by registered dieticians, behavioral counselors, or exercise specialists trained in lifestyle counseling. At each session, subjects were weighed, their self-monitoring records were reviewed, and a new lesson was presented.
Complete physical assessments were performed annually, and subjects were given a $100 honorarium to encourage participation.
“Averaged across the 4 years, participants in the [intervention] group experienced greater improvements in weight, fitness, glycemic control, blood pressure, and levels of HDL-C and triglycerides than those in the [usual care] group,” Dr. Wing and her colleagues said (Arch. Intern. Med. 2010;170:1566-75).
“The mean maximal weight loss (8.6%) in the [intervention] group occurred at 1 year, but participants ... maintained a mean weight loss of 4.7% at year 4, compared with 1.1% in the [usual-care] group,” they noted.
At 1-year follow-up, cardiovascular fitness increased by 20% in the intervention group and 5% in the usual-care group. It regressed over time, but at year 4 the fitness level of the intervention group was still 5% over the baseline level, while that of the usual-care group was 1% below baseline level.
The intervention group maintained greater improvements than did the usual-care group in systolic blood pressure, HbA1c levels, and HDL-C levels, but initial improvements in diastolic blood pressure and triglycerides disappeared by year 4. There were no differences between the two groups in improvement in LDL-C levels.
“This study shows that lifestyle interventions can produce long-term weight loss and improvement in fitness and sustained beneficial effects on CVD risk factors,” the investigators said.
“Although the differences between the two groups were greatest initially and decreased over time for several measures, the differences between the groups averaged across the 4 years were substantial and indicate that the [intervention] group spent a considerable time at lower CVD risk,” they added.
“Longer follow-up will allow us to determine whether the differences between groups in CVD risk factors can be maintained and whether the [intensive intervention] has positive effects on cardiovascular morbidity and mortality,” Dr. Wing and her associates said.
Disclosures: The LookAHEAD study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; Office of Research on Women’s Health; Centers for Disease Control and Prevention; U.S. Department of Veterans Affairs; Indian Health Service; and general clinical research centers at Johns Hopkins Medical Institutions, Massachusetts General Hospital, Massachusetts Institute of Technology, Colorado Health Sciences Center, University of Tennessee at Memphis, and the University of Pittsburgh. In addition, FedEx Corp., Health Management Resources, LifeScan Inc., OPTIFAST, Hoffmann-La Roche, Abbott Nutrition, and Slim-Fast have committed to make major contributions to the ongoing trial. Dr. Wing’s associates reported financial ties to BodyMedia Inc., University of Pittsburgh Medical Center Health Plan, Proctor & Gamble, and Free & Clear.
An intensive lifestyle intervention produced significant improvements in weight, cardiovascular fitness, blood pressure, hemoglobin A1c, triglycerides, and HDL-cholesterol, which were largely maintained throughout 4 years of follow-up, according to a report in the Sept. 27 issue of the Archives of Internal Medicine.
The study, involving 5,145 overweight or obese patients with type 2 diabetes, compared the intensive intervention against usual patient care, which included standard diabetes education. “Effects of the magnitude that we observed for fitness, HDL-C and HbA1c levels, and blood pressure have been associated with decreased cardiovascular events and mortality in previous medication trials and observational studies.
“The critical question is whether the differences between groups in risk factors will translate into differences in the development of CVD [cardiovascular disease]. These results will not be available for several additional years,” said Rena R. Wing, Ph.D., of the department of psychiatry at Miriam Hospital/ Brown University, Providence, R.I., and her associates in the LookAHEAD (Action for Health in Diabetes) trial.
The LookAHEAD researchers previously reported on the 1-year benefits of the intensive lifestyle intervention, compared with usual care. They now report that patients who received the intervention were able to maintain the positive changes they made for 3 more years, albeit with some degree of regression to baseline levels of all measures.
The trial enrolled subjects aged 45-76 years at 16 U.S. medical centers. Approximately 60% of the subjects were women, and 37% were from racial or ethnic minorities. The average body mass index was 36 kg/m2, and the average duration of diabetes was more than 6 years.
A total of 2,570 subjects were randomly assigned to the intensive intervention and 2,575 to usual care with diabetes education.
The intervention included dietary modification with a calorie goal of 1,200-1,800 kcal/d, less than 30% of calories from fat, and at least 15% of calories from protein. A portion-controlled diet was provided. The exercise goal was at least 175 minutes of physical activity per week at an intensity level comparable to that of brisk walking. Behavioral strategies included self-monitoring, goal setting, and problem solving.
Subjects in the intervention group met individually and in groups every week for the first 6 months and 3 times per month for the next 6 months. During years 2 through 4, they were seen individually at least once a month, contacted by phone or e-mail once a month, and attended three group sessions and assorted group classes throughout the year.
These sessions were led by registered dieticians, behavioral counselors, or exercise specialists trained in lifestyle counseling. At each session, subjects were weighed, their self-monitoring records were reviewed, and a new lesson was presented.
Complete physical assessments were performed annually, and subjects were given a $100 honorarium to encourage participation.
“Averaged across the 4 years, participants in the [intervention] group experienced greater improvements in weight, fitness, glycemic control, blood pressure, and levels of HDL-C and triglycerides than those in the [usual care] group,” Dr. Wing and her colleagues said (Arch. Intern. Med. 2010;170:1566-75).
“The mean maximal weight loss (8.6%) in the [intervention] group occurred at 1 year, but participants ... maintained a mean weight loss of 4.7% at year 4, compared with 1.1% in the [usual-care] group,” they noted.
At 1-year follow-up, cardiovascular fitness increased by 20% in the intervention group and 5% in the usual-care group. It regressed over time, but at year 4 the fitness level of the intervention group was still 5% over the baseline level, while that of the usual-care group was 1% below baseline level.
The intervention group maintained greater improvements than did the usual-care group in systolic blood pressure, HbA1c levels, and HDL-C levels, but initial improvements in diastolic blood pressure and triglycerides disappeared by year 4. There were no differences between the two groups in improvement in LDL-C levels.
“This study shows that lifestyle interventions can produce long-term weight loss and improvement in fitness and sustained beneficial effects on CVD risk factors,” the investigators said.
“Although the differences between the two groups were greatest initially and decreased over time for several measures, the differences between the groups averaged across the 4 years were substantial and indicate that the [intervention] group spent a considerable time at lower CVD risk,” they added.
“Longer follow-up will allow us to determine whether the differences between groups in CVD risk factors can be maintained and whether the [intensive intervention] has positive effects on cardiovascular morbidity and mortality,” Dr. Wing and her associates said.
Disclosures: The LookAHEAD study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; Office of Research on Women’s Health; Centers for Disease Control and Prevention; U.S. Department of Veterans Affairs; Indian Health Service; and general clinical research centers at Johns Hopkins Medical Institutions, Massachusetts General Hospital, Massachusetts Institute of Technology, Colorado Health Sciences Center, University of Tennessee at Memphis, and the University of Pittsburgh. In addition, FedEx Corp., Health Management Resources, LifeScan Inc., OPTIFAST, Hoffmann-La Roche, Abbott Nutrition, and Slim-Fast have committed to make major contributions to the ongoing trial. Dr. Wing’s associates reported financial ties to BodyMedia Inc., University of Pittsburgh Medical Center Health Plan, Proctor & Gamble, and Free & Clear.
Major Finding: Overweight or obese patients with type 2
diabetes who received an intensive lifestyle intervention were able to
maintain significantly better weight loss and improvements in
cardiovascular fitness, glycemic control, and CVD risk factors over 4
years than were patients who received usual care.
Data Source: A government- and industry-funded randomized trial involving 5,145 patients treated at 16 U.S. medical centers.
Disclosures:
The LookAHEAD study was supported by the National Institute of Diabetes
and Digestive and Kidney Diseases; National Heart, Lung, and Blood
Institute; National Institute of Nursing Research; National Center on
Minority Health and Health Disparities; Office of Research on Women's
Health; Centers for Disease Control and Prevention; U.S. Department of
Veterans Affairs; Indian Health Service; and general clinical research
centers at Johns Hopkins Medical Institutions, Massachusetts General
Hospital, Massachusetts Institute of Technology, Colorado Health
Sciences Center, University of Tennessee at Memphis, and the University
of Pittsburgh. In addition, FedEx Corp.n, Health Management Resources,
LifeScan Inc., OPTIFAST, Hoffmann-La Roche, Abbott Nutrition, and
Slim-Fast have committed to make major contributions to the ongoing
trial. Dr. Wing’s associates reported financial ties to BodyMedia Inc.,
University of Pittsburgh Medical Center Health Plan, Proctor &
Gamble, and Free & Clear.